在非小细胞肺癌中m6ARNA甲基化调节者的表达模式和预后作用
Ming Zhang1, Congbo Yang2, Wen Dong3
1Department of Radiotherapy, The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Hospital, Kunming, China. Zhangmingynszlyy@gmail.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|March 2, 2024
概括
这项研究揭示了m6ARNA甲基化调节剂,特别是IFG2BP2和METTL14,可以预测非小细胞肺癌 (NSCLC) 的预后. 基于这些基因的风险评分模型有效地区分高风险和低风险NSCLC患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) RNA甲基化对癌症的发展至关重要.
- 了解m6A调节器在非小细胞肺癌 (NSCLC) 中的作用对于预后至关重要.
研究的目的:
- 探索NSCLC中m6ARNA甲基化调节者的表达模式和预后意义.
- 为NSCLC患者开发预后风险评分模型.
主要方法:
- 利用了癌症基因组图谱 (TCGA) 数据库与422名NSCLC患者的数据.
- 使用R语言进行统计分析,包括LASSO Cox回归.
- 建立了一个基于已识别的m6A调节器的预后风险评分模型.
主要成果:
- m6A基因变异与瘤等级和阶段有显著的相关性.
- 确定IFG2BP2和METTL14作为风险分析的关键m6A监管者.
- 低风险组的整体生存率明显高于高风险组.
结论:
- 基于m6A的预后风险评分模型可以预测NSCLC患者的结果.
- IFG2BP2和METTL14显示出作为NSCLC预后分子标记物的潜力.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Stability
33.5K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.5K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Regulation of Expression at Multiple Steps
906
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
906


